No. 77

August 2011

Headline News Innovation and Development

Applied Technology

Basic Science Cooperation between CAS and Local Authorities
Bioscience International Cooperation Brief News Geoscience
Innovation and Development

Substantial Step Forward: Therapeutic Vaccine for Anti-HBV

The pathogenic microorganism research group of the Institute of Microbiology, CAS has studied the immunological function of heat shock protein gp96 since 1997. They have explored the cellular immunity mediated by gp96 in the HBV infection and have made important progress. In 2011, based on previous research, which shows that the regulatory T cells £®Treg£©may play a negative role in the gp96-mediated T-cell responses, the research team led by Dr. Meng Songdong further found that eliminating Treg could remarkably increase the T cell immunological competence and anti-tumor activity by gp96, which provides bases for enhancing the immunological activity of gp96 vaccine and may help to design more potent autologus gp96 cancer vaccines which are currently being used in clinical trials. In the HBV transgenic mouse model, gp96 therapeutic vaccine was found to efficiently activate T cell immune response and eliminate HBV virus; gp96 adjuvant vaccine could effectively activate HBV-specific T cell responses and decrease Tregs in transgenic mouse. After 5-8 weeks of immunization, the viral S antigen in the serum was decreased by more than 50%, the copy numbers of viral DNA were decreased by more than 1000 times, and more than 95% of the virus in liver were eliminated, which demonstrate that gp96 therapeutic vaccine could effectively break the immune tolerance and activate T cell response to inhibit HBV. This research provides basis for developing gp96 based HBV therapeutic vaccine. Meanwhile, it is the first time to express recombined gp96 protein with immunological competence in the yeast Hansenula, facilitating for researching gp96 biological function and developing adjuvant vacciness. These results have been published in the Cancer Immunology Immunotherapy£¨Vaccine and Journal of Biotechnology respectively in 2011, and two Chinese inventive patents have been applied.

Breakthrough in Research on Cascaded Laser Wakefield Accelerator

A research group led by Xu Zhizhan and Li Ruxin of the State Key Laboratory of High Field Laser Physics, Shanghai Institute of Optics and Fine Mechanics,CAS published a paper on Phys. Rev. Lett. 107£¨035001£®2011£©£©on July 15th, which reports the scheme of firstly adopting an all-optical cascaded laser wakefield accelerator using ionization-induced injection, and it successfully separated and controlled the two basic physical process of electron injection and acceleration. The experiment has made groundbreaking achievement of producing quasi- monoenergetic electron beams with near-GeV energy, ultrahigh accelerating gradient of 187 GV/m, etc. The successful realization of the Cascaded Laser Wakefield Accelerator has provided feasible approach to generate high-performance monoenergetic electron beam with 10-GeV-class or higher energy, and it has a far-reaching influence on the table-top particle accelerator.

Other Issues
Seventy-sixth Issue (June 2011)
Seventy-fifth Issue (April 2011)
Seventy-forth Issue (February 2011)
Seventy-third Issue (December 2010)
Seventy-second Issue (October 2010)
Seventy-first Issue (August 2010)
Seventieth Issue (June 2010)
Sixty-nineth Issue (April 2010)
Sixty-eighth Issue (February 2010)

Sixty-seventh Issue (December 2010)

Sixty-sixth Issue (October 2009)
Sixty-fifth Issue (August 2009)
Sixty-fourth Issue (June 2009)
Sixty-third Issue (April 2009)
Sixty-second Issue (February 2009)
Sixty-first Issue (December 2008)
Sixtieth Issue (October 2008)
Fifty-nineth Issue (August 2008)
Fifty-eighth Issue (June 2008)
Fifty-seventh Issue (April 2008)
Fifty-sixth Issue (February 2008)
Fifty-fifth Issue (December 2007)
Fifty-fourth Issue (October 2007)
Fifty-third Issue (August 2007)
Fifty-second Issue (June 2007)
Fifty-first Issue (April 2007)
Fiftith Issue (Feb. 2007)
Fourty-nineth Issue (December, 2006)
Fourty-eighth Issue (Ocboter, 2006)
Fourty-seventh Issue (August, 2006)
Fourty-sixth Issue (June, 2006)
Fourty-fifth Issue (April, 2006)
Fourty-fourth Issue (February, 2006)

copyright © 1998-2015
CAS Newsletter Editorial Board: 52, Sanlihe Road, Beijing 100864, CHINA